Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00258115 · ClinicalTrials.gov registry record · Phase 2

The Study of Inflammation on Blood Glucose Levels in Obese People

A Phase 2 study, sponsored by Joslin Diabetes Center.

Completed
Registry status
Phase 2
Development phase
20
Enrollment target

NCT00258115: Completed Phase 2 study, sponsored by Joslin Diabetes Center.

NCT00258115 is a Phase 2 study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00258115, a Phase 2 study, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
Phase 2
Development phase
20 participants
Enrollment target

Study Summary

Chronic subaccute inflammation may underlie the development of diabetes cardiovascular disease and other components of the metabolic syndrome. Rodent studies suggest diet induced obesity is associated with activation of the IKK/NF-kB pathway and this pathway can be inhibited by salicylates. This study seeks to determine the effect of salicylates in overweight persons.

Interventions

  • DRUG salsalate

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2003-12
Phase Phase 2
Joslin Diabetes Center

73 total trials

What the finished NCT00258115 record still lists

NCT00258115 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which salsalate is the first listed.

NCT00258115 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00258115 about?

NCT00258115 is a clinical study titled "The Study of Inflammation on Blood Glucose Levels in Obese People". Chronic subaccute inflammation may underlie the development of diabetes cardiovascular disease and other components of the metabolic syndrome. Rodent studies suggest diet induced obesity is associated with activation of the IKK/NF-kB pathway and this pathway can be inhibited by salicylates. This stu...

What is the current status of trial NCT00258115?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2003-12.

What interventions are being tested in trial NCT00258115?

The interventions under investigation include: salsalate (DRUG).

Who is sponsoring clinical trial NCT00258115?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00258115's enrollment target sits among peer trials

20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00258115, the US trial registry maintained by the National Library of Medicine. NCT00258115 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.